Current role
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
2026-07-16–present
Uri Tadelis
Equibles does not estimate personal net worth.
Get an email with a short summary when Raphael Pharmaceutical Inc. publishes a filing, an earnings call transcript or a press release.
Get RAPH alertsAbout Uri Tadelis
Uri Tadelis is recorded as CFO at Raphael Pharmaceutical Inc. (RAPH) since July 16, 2026. Raphael Pharmaceutical Inc. reported in an 8-K filed July 17, 2026 that Uri Tadelis was appointed Chief Financial Officer, effective July 16, 2026. Raphael Pharmaceutical Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Raphael Pharmaceutical Inc. includes Ajay Kumar Dhadha (Chairman and Board Member), DR.IGAL LOURIA HAYON (CTO), Dr. Igal Louria Hayon (Board Member) and 1 other.
“Effective July 16, 2026, the Company appointed Mr. Uri Tadelis as its Chief Financial Officer.”
Affiliation history
-
Current
2026-07-16–present
Company network
Leadership on record at Raphael Pharmaceutical Inc.
- Ajay Kumar Dhadha Chairman, Board Member
- DR.IGAL LOURIA HAYON CTO
- Dr. Igal Louria Hayon Board Member
- Zvi Laufer Laor Board Member